Register entry
CHIMERIX INC
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 7
- Exclusivities
- 1
- Countries
- 0
Exclusivity
Patents and exclusivities
7| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 9629842 | MODEYSOdordaviprone hydrochloride | use | Apr 2032 |
| RE46290 | MODEYSOdordaviprone hydrochloride | use | Aug 2032 |
| 9265765 | MODEYSOdordaviprone hydrochloride | product | Jul 2034 |
| 11976068 | MODEYSOdordaviprone hydrochloride | product | Mar 2036 |
| 10172862 | MODEYSOdordaviprone hydrochloride | use | Jan 2037 |
| 10369154 | MODEYSOdordaviprone hydrochloride | use | Jan 2037 |
| 12102639 | MODEYSOdordaviprone hydrochloride | use | Jan 2037 |
| Product | Exclusivity | Until |
|---|---|---|
| MODEYSODORDAVIPRONE HYDROCHLORIDE | ODE-547 Orphan drug | Aug 2032 |
Enquiry
Common questions
- Is CHIMERIX INC FDA approved?
- CHIMERIX INC holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.